newsfilter
← Latest News
PR Newswire·

Investors in Vistagen Therapeutics, Inc. Should Contact The Gross Law Firm Before March 16, 2026 to Discuss Your Rights - VTGN

  • The Gross Law Firm issued a securities class action notice for Vistagen Therapeutics, Inc. (NASDAQ: VTGN) on January 29, 2026.
  • The class period for potential claims spans from April 1, 2024, to December 16, 2025.
  • The complaint alleges defendants made misleading statements while concealing negative facts regarding the Phase 3 PALISADE-3 trial for fasedienol, an investigational treatment for social anxiety disorder.
  • On December 17, 2025, Vistagen announced the trial failed to meet its primary endpoint, resulting in no statistically significant improvement over placebo.
  • Following the announcement, VTGN stock dropped from $4.36 on December 16, 2025, to $0.86 on December 17, 2025, a decline exceeding 80%.
  • The deadline to register as a lead plaintiff is March 16, 2026.
  • Shareholders can register via a provided link to enroll in portfolio monitoring for case updates.
  • Participation in the class action involves no cost or obligation to shareholders.